Current Liabilities
Accrued Liabilities, Current
Kailera Therapeutics Accrued Liabilities, Current increased by 23.5% to $46.71M in Q1 2026 compared to the prior quarter.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2025
Last reportedQ1 2026May 26, 2026
How to read this metric
An increase may reflect growing operational scale or timing differences in payments, while a decrease suggests efficient settlement of short-term obligations.
Detailed definition
This represents obligations for expenses that have been incurred but not yet invoiced or paid by the end of the reportin...
Peer comparison
Standard operational metric across all industries; levels correlate with company size and payroll cycles.
Metric ID:
current_liabilities_accrued_liabilities_currentHistorical Data
2 periods
| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $37.84M | $46.71M |
| QoQ Change | — | +23.5% |
Range$37.84M – $46.71M
Accrued Liabilities, Current at Other Companies
Frequently Asked Questions
- What is Kailera Therapeutics 's accrued liabilities, current?
- Kailera Therapeutics (KLRA) reported accrued liabilities, current of $46.71M in Q1 2026.
- What does accrued liabilities, current mean?
- Money owed for services or expenses that have been incurred but not yet paid.